The approach extends targeted protein degradation beyond the intracellular proteins commonly directed to the ubiquitin–proteasome system by PROTACs and molecular glues. The proteasome acts principally in the cytosol and nucleus, making it poorly suited to many secreted factors, extracellular proteins and membrane receptors, including cytokines, growth factors, immune checkpoints, receptor tyrosine kinases, adhesion receptors and transporters. Neutralizing or inhibiting these proteins can leave catalytic, scaffolding, ligand-independent or recycling-dependent functions intact, whereas eliminating them may provide a distinct pharmacological profile. Lysosome-targeting degraders, including LYTAC-like chimaeras, exploit cellular entry pathways naturally connected to extracellular and membrane cargo.

Early LYTAC designs linked a target-binding antibody to mannose-6-phosphate ligands that recruit the cation-independent mannose-6-phosphate receptor, CI-M6PR, also known as IGF2R. Later systems used the hepatocyte-enriched asialoglycoprotein receptor, ASGPR, often with triantennary N-acetylgalactosamine ligands, to direct uptake toward the liver. These approaches established the central principle of induced proximity: a bifunctional molecule can connect an extracellular or cell-surface target to an endogenous receptor and thereby bring it into the endolysosomal system. The field has since expanded to bispecific biologics, antibody fragments, ligand- and cytokine-guided chimaeras, compact synthetic degraders, aptamers, nucleic-acid scaffolds, polymers, nanoparticles, vesicles and genetically encoded systems.

Internalization, however, does not prove degradation. Once a target–degrader complex enters an endosome, it may be recycled to the plasma membrane, transported retrogradely, moved across a cell by transcytosis, retained in a non-degradative compartment or delivered to a lysosome. The review therefore treats receptor identity, binding kinetics, valency, geometry, linker length and rigidity, and complex lifetime as tools for controlling post-endocytic fate. Multivalent engagement can enhance avidity and, in suitable systems, promote receptor clustering, while pH-responsive interactions may release a recruited receptor in an acidifying endosome without releasing the target. Receptors already inclined toward lysosomal delivery may offer an advantage over handles chosen solely for rapid uptake.

Membrane proteins face an additional hurdle. After internalization, a transmembrane protein generally remains within the limiting membrane of an endosome and must enter intraluminal vesicles of multivesicular bodies before the full-length protein can be efficiently destroyed. Sorting of this kind can depend on receptor clustering, ubiquitination, membrane context, adaptor recruitment and the ESCRT machinery. For receptors such as EGFR, immune checkpoints, adhesion proteins and transporters, the design question is therefore not simply whether target and receptor can be internalized together, but whether the complex is committed to a degradative vesicular pathway. Recycling, retrograde transport, transcytosis and non-degradative endosomal retention are distinct failure modes rather than interchangeable evidence of activity.

The review proposes a five-tier evidence framework to distinguish binding and uptake from genuine destruction. Tier 1 covers target engagement and cellular uptake, establishing only that capture and delivery are feasible. Tier 2 requires reproducible, dose- and time-dependent reduction in total target protein, supported by orthogonal assays and controls for viability, assay interference and major changes in expression. Tier 3 is the decisive step: the reduction in total target must be reversed or substantially attenuated by an appropriate perturbation of lysosomal acidification or proteolysis. Tier 4 adds mechanistic evidence involving receptor dependence, trafficking, recycling, receptor fate and, for membrane proteins, multivesicular-body sorting, ubiquitination or ESCRT involvement. Tier 5 concerns translation, requiring target reduction in relevant tissues or cell populations alongside exposure, pharmacokinetic–pharmacodynamic relationships, selectivity and tolerability. The tiers assess a particular target, construct and biological context rather than assigning an intrinsic maturity level to an entire platform.

Surface flow cytometry, fluorescence uptake, microscopy and reduced surface staining can support target engagement or altered accessibility, but they cannot independently establish degradation. Apparent signal loss may result from epitope masking, target shedding, redistribution, conformational change, assay interference or receptor clustering. Quantitative immunoblotting, proteomics, targeted mass spectrometry, non-competing immunoassays, permeabilized flow cytometry and other orthogonal methods can help establish loss of the full target. Lysosomal inhibitors such as bafilomycin A1, concanamycin A, chloroquine, hydroxychloroquine and lysosomal protease inhibitors can test dependence, but they also affect endosomal trafficking, secretion, autophagic flux, signaling and cell fitness. Their use therefore requires viability controls and, where appropriate, target RNA measurements and complementary protein assays. Dose-response, time-course, washout and recovery experiments further distinguish durable depletion followed by resynthesis from redistribution or persistent assay interference.

Receptor selection creates opportunities but also imposes distinct liabilities. Broadly expressed CI-M6PR can provide access to lysosomal trafficking machinery, whereas ASGPR offers a liver-biased clearance sink for plasma-accessible targets. Sortilin and members of the low-density lipoprotein receptor-related protein family may suit extracellular clearance, aggregate removal or barrier transport, depending on cell context. Transferrin receptor 1 is widely used for uptake and blood–brain-barrier transport, but its recycling and transcytosis behavior must be redirected if degradation is intended. Disease-enriched handles, including prostate-specific membrane antigen, glypican-3, carbonic anhydrase IX and folate receptor alpha, can improve tissue selectivity, although their expression is often heterogeneous among patients, lesions and anatomical regions. Signaling-active cytokine, chemokine and hormone receptors may distinguish cell populations, but they can also alter pathways including JAK–STAT, PI3K–AKT, MAPK, calcium signaling, chemotaxis, desensitization and receptor downregulation. Attenuated ligands, antagonist-like binders, affinity tuning, altered subunit selectivity and geometric control may preserve uptake while reducing unwanted biological effects.

Molecular format adds another layer of control. Antibodies and other modular biologics offer high affinity, epitope selection and adjustable valency, but their size can limit penetration into solid tumors, dense extracellular matrices and protected compartments. For IgG-based constructs, Fc-receptor engagement, immune-complex behavior and neonatal Fc receptor recycling can also influence biodistribution, persistence and uptake independently of the intended mechanism. Compact small molecules or peptides may diffuse more readily and permit precise control of linker polarity, rigidity, plasma stability and pH sensitivity, yet many extracellular proteins lack suitable compact binders, and small constructs may be rapidly filtered, degraded or otherwise cleared before sufficient target capture occurs. Multivalent polymers, nucleic-acid assemblies, nanocages and vesicles can control ligand spacing and local concentration, but excessive size or valency may promote nonspecific uptake, clearance-organ accumulation, receptor sequestration or unstable endosomal complexes. Architectural novelty is not itself evidence of degradation; formats must be compared by sustained total target loss, lysosomal dependence, mechanistic clarity and translational performance.

Translating this strategy will require matching the dominant biological bottleneck to the design. Plasma-accessible soluble proteins may suit repeated systemic capture through a high-capacity clearance route, whereas tissue-resident membrane targets require penetration, selective cell access and sustained post-endocytic commitment. Targets behind anatomical barriers present two separate problems: crossing the barrier and achieving lysosomal degradation within the intended cell. Immune, inflammatory and endocrine applications also require monitoring of feedback, target resynthesis and receptor signaling. Safety assessments must examine competition with endogenous ligands, receptor capacity, off-tissue loss, inflammatory activation, immunogenicity and biodistribution, while manufacturing must control conjugation, valency, particle size, stability and batch consistency. Spatial proteomics, surface proteomics, multiplex imaging and single-cell profiling may help identify where target, recruited handle and degradative machinery coexist and distinguish delivery failure from routing failure. The review’s central conclusion is that the field must advance from demonstrating uptake to controlling intracellular fate, because only verified lysosomal destruction—not binding, disappearance from the cell surface or fluorescent uptake—establishes successful targeted lysosomal degradation.

Subject of Research: Design and validation of targeted lysosomal degraders for extracellular and membrane proteins

Article Title: Targeted Lysosomal Degradation of Extracellular and Membrane Proteins: From Receptor Hijacking to Programmable Endolysosomal Routing

Article References: Liu, K., Wang, X., Liu, X., He, C., Qian, D., Meng, X., & Zhu, L. (2026). Targeted Lysosomal Degradation of Extracellular and Membrane Proteins: From Receptor Hijacking to Programmable Endolysosomal Routing. Advanced Science, 13(58), Article e77675. https://doi.org/10.1002/advs.77675

Image Credits: AI Generated

DOI: 10.1002/advs.77675

Keywords: targeted protein degradation, lysosomal degradation, LYTACs, endolysosomal routing, membrane proteins, receptor recruitment, protein therapeutics, molecular design, drug discovery, extracellular proteins, Targeted, Lysosomal

Sukunaarchaeum belongs to the archaea, a domain of single-celled organisms that, while superficially resembling bacteria, are fundamentally distinct in their molecular biology. Archaea share features with both bacteria and eukaryotes — the domain that includes plants, animals and fungi — and they are renowned for thriving in extreme environments as well as for playing crucial roles in ocean ecosystems. Yet the newly described microbe is unlike any archaea catalogued before. Its genome is less than half the size of the smallest archaeal genome previously known, and it contains just 189 protein-coding genes. To put that in perspective, many free-living bacteria carry several thousand such genes, and even the most streamlined parasitic bacteria typically retain hundreds more than Sukunaarchaeum does.

What makes this tiny genome so scientifically compelling is not simply its size, but its composition. Sukunaarchaeum has lost almost all of the genes needed to produce its own nutrients and generate energy, suggesting that it depends heavily on other organisms for the resources it needs to survive. In stark contrast, it has retained the genes required to copy its DNA and to translate genetic information into proteins — the twin processes of replication and gene expression that lie at the heart of cellular life. In other words, while it has surrendered nearly everything related to metabolism, it has clung fiercely to the informational core that allows it to reproduce itself as a distinct genetic entity.

Professor Thorsten Allers, from the School of Life Sciences at the University of Nottingham and co-author of the study, emphasised the significance of this balance. The key to defining life, he noted, is whether something can replicate itself, and whether it can do so autonomously. The discovery, he said, provides new clues about how simple a living cell can become while remaining capable of reproducing and maintaining its own genetic information. Although Sukunaarchaeum has lost almost all of the genes needed to make nutrients and energy, it has kept much of the machinery required to copy its genome and produce proteins from its genetic information — a combination that, according to Allers, suggests the microbe may be close to the minimum level of genetic information needed for an organism to remain an independent cell.

The evolutionary path taken by Sukunaarchaeum appears to be strikingly different from that of other organisms with extremely reduced genomes. Mitochondria, the power-generating structures inside our own cells, and chloroplasts, which enable plants to perform photosynthesis, were once free-living bacteria. Over billions of years of symbiosis, they transferred most of their genes to their host cells’ genomes and now rely on their hosts for much of the machinery needed to replicate and express what genetic information they have left. Sukunaarchaeum, by contrast, appears to have held onto its own replicative and translational apparatus even as it shed its metabolic capabilities, occupying a curious middle ground between a fully independent cell and a degenerate organelle.

The discovery itself was serendipitous in the way that many landmark findings in microbiology are. The research team encountered Sukunaarchaeum while analysing the genetic material of individual marine microorganisms collected from plankton samples. Rather than culturing the organism in a laboratory dish — a step that has never been achieved for this microbe — the scientists reconstructed its genome from genetic sequences recovered directly from the marine environment. This approach, known as metagenomics, has revolutionised the study of microbial life by revealing vast numbers of organisms that have never been grown in the lab or even seen under a microscope.

Genetic analysis revealed that Sukunaarchaeum is not merely unusual in its genome size; it is also profoundly distinct from all previously known groups of archaea. Related genetic sequences found in other marine samples suggest that Sukunaarchaeum is part of a much larger group of organisms that has so far gone largely unnoticed by science. This hidden lineage hints at an entire branch of the tree of life waiting to be explored, raising the tantalising possibility that the oceans harbour many more ultra-reduced microbes whose existence has been overlooked simply because they are difficult to detect and impossible to culture by conventional means.

One of the most intriguing features of the Sukunaarchaeum genome is that around a quarter of it consists of genes encoding unusually large membrane proteins whose functions are not yet known. Similarly large membrane proteins are found in some parasitic archaea, and this shared characteristic raises the possibility that Sukunaarchaeum may live as a parasite inside or alongside another organism. Membrane proteins sit at the boundary between a cell and its surroundings, and in parasites they often serve to extract resources from a host or to manipulate host biology. If Sukunaarchaeum does indeed lead a parasitic lifestyle, its enormous membrane proteins could be the molecular tools it uses to siphon nutrients from its unwitting partner — a hypothesis that future research will need to test.

Despite the completeness of the genome reconstruction, important mysteries remain. The scientists have not yet directly observed Sukunaarchaeum, nor have they identified the host organism on which it may depend. The team plans to investigate where the microbe lives, what it depends on, and how it interacts with other organisms — questions that will require new sampling campaigns, advanced imaging techniques and possibly single-cell genomics approaches. Finding the host could illuminate the precise nature of the symbiotic or parasitic relationship, and observing the organism itself would confirm that the reconstructed genome corresponds to a real, functioning cell rather than an artefact of genetic sampling.

Beyond its immediate novelty, the discovery of Sukunaarchaeum carries implications for some of the deepest questions in biology. Understanding the limits of life — how much genetic information an organism needs to survive and reproduce — informs fields ranging from evolutionary biology to the search for life beyond Earth, where scientists look for the simplest signatures of living systems. It also resonates with efforts to build artificial minimal cells in the laboratory, where researchers attempt to design genomes containing only the genes essential for life. Sukunaarchaeum, sculpted by natural selection over immense stretches of time, provides a real-world benchmark for these endeavours: a naturally occurring genome that has been stripped down to what may be very near the informational minimum for cellular life. As researchers continue to probe the hidden microbial diversity of the oceans, this tiny archaeal god of the plankton may prove to be one of the most instructive organisms ever found.

Subject of Research: An ultra-reduced archaeal genome defining the minimal genetic requirements for cellular life

Article Title: Tiny marine microbe sheds new light on how little genetic machinery a cell needs to survive

Article References: Tiny marine microbe sheds new light on how little genetic machinery a cell needs to survive. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: archaea, minimal genome, Sukunaarchaeum, marine microbiology, metagenomics, plankton, genome reduction, parasitism, evolutionary biology, Current Biology, limits of life, membrane proteins

The research team, led by Yijie Liu and Jie Teng, worked with fresh leaves of the ‘Gougunao Tea No. 2’ cultivar harvested in Jiangxi Province, China. Their target was a purification strategy called three-phase partitioning, or TPP, a chromatography-free separation technique in which t-butanol and water, normally miscible, are forced apart by adding ammonium sulfate. Under the right conditions, proteins gather into a distinct middle phase between the upper organic layer, which collects oils and lipid-soluble material, and the lower aqueous layer, which retains polysaccharides and other water-soluble compounds. TPP is prized for its simplicity, high recovery rates and easy scalability, and it has already been applied to polyphenol oxidase from several sources. The problem is the solvent: t-butanol is flammable, volatile and ecotoxic, and highly polar organic solvents can disrupt the hydrophobic interactions that hold membrane proteins in their native shape, accelerating the loss of enzyme activity during purification.

To replace t-butanol, the researchers turned to deep eutectic solvents, a class of liquids first described by Abbott and colleagues in 2004. Deep eutectic solvents form when a hydrogen bond acceptor and a hydrogen bond donor self-assemble through an extensive hydrogen bonding network, producing a liquid with a melting point far below that of either component. They are simple to prepare, biodegradable, low in toxicity and highly biocompatible, and their physicochemical properties can be tuned by choosing different component pairs. Previous work has shown that these solvents can stabilize proteins in vitro through hydrogen bonding and hydrophobic forces, which made them attractive candidates for a green version of TPP. However, no one had applied a deep eutectic solvent-based TPP system to a membrane-bound polyphenol oxidase, and the molecular mechanisms behind any such purification remained unexplored.

The team prepared nine different deep eutectic solvents from combinations of hydrogen bond acceptors and donors, including pairs such as tetracaine with thymol, menthol with octanoic acid, and procainamide derivatives with fatty acids. Fourier transform infrared spectroscopy confirmed that each mixture had formed a genuine eutectic: carbonyl stretching peaks shifted to lower frequencies, and the broad hydroxyl absorption bands of the individual components merged into single strong peaks, signatures of newly created intermolecular hydrogen bonds. Proton nuclear magnetic resonance spectroscopy provided further confirmation. The phenolic hydroxyl proton of thymol in the first solvent shifted downfield with clear peak broadening, while the carboxyl protons of several acid-based mixtures vanished entirely from the 8 to 15 ppm region, a consequence of rapid proton exchange within a dense hydrogen bonding network. One solvent, built from menthol and octanoic acid in a one-to-one molar ratio and designated DES-5, showed the largest downfield shift of all, indicating the strongest hydrogen bonding in the entire set.

When the nine solvents were tested against crude tea mPPO extract, DES-5 stood out decisively. It delivered an enzyme activity of 2117 units and a purification fold of 17.43, with a specific activity of 50,652 units per milligram, significantly outperforming t-butanol and every other solvent tested. The authors attribute this to a combination of favorable mass transfer properties and a useful side effect: the solvent appears to denature some contaminating proteins, which raises the purification fold of the target enzyme. Single-factor experiments then mapped how the process responded to changing conditions. Enzyme activity and purification fold both peaked at 45 percent ammonium sulfate, a concentration high enough to salt out proteins through hydrophobic aggregation but low enough to avoid irreversible conformational damage. The optimal solvent-to-extract ratio was 2:1 by volume, beyond which excess solvent began to denature the enzyme itself. Extraction time peaked at 75 minutes, after which prolonged exposure to air and light caused oxidative losses, and the ideal temperature was 30 degrees Celsius, where the lower viscosity of the warm solvent improved mass transfer before thermal inactivation set in.

Response surface methodology refined these parameters into a precise recipe. A Box-Behnken design produced quadratic regression models for both enzyme activity and purification fold, with coefficients of determination of 0.9966 and 0.9992 respectively, indicating excellent fit and predictive reliability. The statistically optimal conditions were 47.2 percent ammonium sulfate, 74.8 minutes of extraction and a solvent ratio of 1.98:1. Rounded to practical values of 47 percent, 75 minutes and 2:1, three replicate validations yielded an average activity of 1967 units and a purification fold of 16.64, with prediction errors below one percent and no statistically significant difference from the theoretical values. The optimized process was thus both accurate and reproducible.

Physical characterization reinforced the case for the green solvent. Scanning electron microscopy revealed that crude mPPO formed irregular porous aggregates with rough edges and abundant protein debris. After t-butanol-based purification, the particles became dense, fragmented shards, a morphology the authors link to organic-solvent-induced aggregation. mPPO purified through DES-5, by contrast, emerged as relatively intact block-shaped particles with denser, smoother surfaces and minimal fragmentation, suggesting the deep eutectic solvent provides a gentler separation environment that preserves the morphological integrity of the protein particles.

To understand the mechanism, the researchers built a homology model of tea mPPO from its UniProt sequence, validated it with Ramachandran and ERRAT analyses, and docked the two DES-5 components into the structure. Both menthol and octanoic acid bound with energies more favorable than the minus 5 kilocalories per mole threshold for spontaneous binding. Menthol’s single hydroxyl group acted as both hydrogen bond donor and acceptor, bridging three backbone residues, Gly301, Lys382 and Gly383, with bond lengths between 2.2 and 2.6 angstroms. Octanoic acid anchored its polar head group through hydrogen bonds to Leu531, Thr331 and Asn200, the shortest at just 1.9 angstroms, while surrounding hydrophobic residues constrained its fatty acyl chain and improved shape complementarity within the binding pocket.

Molecular dynamics simulations in GROMACS then tested whether these interactions stabilize or destabilize the enzyme. In three independent 100-nanosecond simulations per system, the protein backbone of both ligand-bound complexes relaxed and stabilized at root-mean-square deviations of roughly 0.20 to 0.26 nanometers, whereas an additive-free control lacking both ligands never reached a plateau and drifted to 0.30 to 0.35 nanometers, clear evidence that menthol and octanoic acid dampen backbone fluctuations. The dicopper catalytic center, restrained to preserve its native type 3 copper geometry, kept its bridging angle centered at 120 to 130 degrees throughout, confirming that ligand binding does not disturb the active site. The radius of gyration held steady at about 2.22 nanometers in both systems, showing no global unfolding, and free energy landscape analysis revealed funnel-shaped topologies converging on compact, low-energy states. In the menthol system the solvent-accessible surface area rose modestly as surface loops rearranged outward, while in the octanoic acid system it decreased as the ligand shielded surface residues, producing a more compact surface conformation.

Taken together, the experiments and simulations tell a coherent story: a menthol and octanoic acid deep eutectic solvent purifies tea membrane-bound polyphenol oxidase more efficiently than t-butanol precisely because its components bind the enzyme gently, through hydrogen bonds and hydrophobic contacts that stabilize rather than disrupt the protein’s native fold. The optimized protocol, 47 percent ammonium sulfate, 75 minutes, a 2:1 solvent ratio and 30 degrees Celsius, achieves a purification fold above 16 in a single chromatography-free step using a biodegradable solvent. Beyond tea, the authors suggest the approach offers a template for the green purification of other membrane-bound enzymes, a class of catalysts central to cellular processes and industrial biocatalysis but long hindered by purification methods that sacrifice the very activity they seek to recover.

Subject of Research: Green purification of tea membrane-bound polyphenol oxidase using deep eutectic solvent-based three-phase partitioning

Article Title: Molecular dynamics provide insights into the purification of tea membrane-bound polyphenol oxidase through three-phase partitioning utilizing an eco-friendly deep eutectic solvent

Article References: Liu, Y., Hou, S., Xiao, S., Wang, Y., Liu, Y., & Teng, J. (2026). Molecular dynamics provide insights into the purification of tea membrane-bound polyphenol oxidase through three-phase partitioning utilizing an eco-friendly deep eutectic solvent. Food Chemistry: X, 39, Article 104529. https://doi.org/10.1016/j.fochx.2026.104529

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104529

Keywords: polyphenol oxidase, deep eutectic solvent, three-phase partitioning, tea, molecular dynamics, enzyme purification, green chemistry, membrane proteins, molecular docking, food chemistry, biocatalysis, protein stability

Nanobodies, the single-domain antibody fragments originally derived from camelids, have become indispensable instruments across modern biology. Because they are compact, remarkably stable, and easy to engineer, they serve as conformational stabilizers, crystallization chaperones, biosensors, intracellular targeting agents, and imaging probes. Clinically, the class has already produced approved drugs such as caplacizumab, and nanobody-based therapeutics are advancing against cancer, autoimmune disorders, and infectious disease. In structural biology, their most celebrated role has been locking fragile membrane proteins into defined functional states, a strategy that made high-resolution structures of G-protein-coupled receptors possible more than a decade ago.

Traditionally, these binders are obtained by immunizing llamas or other animals with the protein of interest, an approach that fails when antigens are toxic, unstable, or require trapping in artificial conditions such as extreme pH or fully liganded states. Synthetic libraries sidestep these constraints entirely. Instead of an immune system, researchers use combinatorial gene libraries encoding billions of randomized antibody fragments, then select binders in vitro. Among the display technologies available, ribosome display is uniquely powerful because it couples each protein to its encoding messenger RNA without any cells, allowing theoretical diversities of 10^12 to 10^13 to be explored in a test tube, far beyond what phage or yeast display can practically achieve.

The existing benchmark, the Seeger concave sybody library, has enabled countless selections, including binders that trap membrane proteins in specific conformations. However, it carries a hidden incompatibility. Its nanobody constructs lack the C-terminal histidine tag that the Legobody system requires to recognize its target. Legobody, an approximately 120-kilodalton scaffold assembled from a sybody, an engineered maltose-binding protein, and a nanobody-binding antibody fragment, dramatically enlarges small protein complexes so that cryo-EM image alignment becomes feasible. Without the tag, every sybody recovered from the established libraries must be subcloned and re-engineered before it can be used, adding days of work and eroding throughput precisely where speed matters most.

The new S1.0 library eliminates that detour by embedding the required C-terminal histidine tag and a short Legobody-compatible linker directly into the library scaffold. But the redesign went beyond a simple tagging exercise. Drawing on structural analyses of published concave sybody-antigen complexes, the team noticed that these synthetic binders engage their targets mainly through the CDR1 and CDR2 loops, unlike natural nanobodies, which typically lean heavily on CDR3. In the concave library, the short seven-residue CDR3 and the largely fixed CDR1 had constrained where binding could occur. The researchers therefore extended CDR3 by one residue, raised the number of randomized positions in CDR3 and CDR1 to seven each, and deliberately reduced variability at one CDR2 position, restricting it to serine, tyrosine, arginine, and glutamate to tune surface chemistry while preserving the concave paratope architecture.

The mathematics of library design dictated careful restraint. Nineteen fully randomized positions would imply a theoretical diversity of roughly 5.2 × 10^24, unreachable by any physical display system. Instead, the team employed semi-randomization, enriching bulky aromatic and charged residues at positions likely to contact antigen while weighting choices according to amino-acid frequencies observed in natural nanobody interfaces, yielding a practical theoretical diversity of 10^18. The gene library itself was assembled through overlapping polymerase chain reactions, Type IIS restriction digestion, and T4 ligation, then transcribed into messenger RNA and stored in aliquots at minus 80 degrees Celsius.

Quality control came from deep sequencing. Approximately 9 × 10^7 reads of the naive library revealed that 98 percent of sequences were unique, and most designed amino-acid compositions at randomized positions matched expectations closely, particularly in CDR1, where 23 of 32 compositions showed discrepancies below 10 percent. Some positions, especially in CDR3, deviated more substantially, a caveat the authors acknowledge, though the overall fidelity confirmed that the construction strategy had faithfully captured the intended chemical space.

Functional validation proceeded against two test proteins. In head-to-head selections against calmodulin, performed in parallel with the benchmark concave library, S1.0 produced 45 positive clones from 96 screened, compared with 61 for the established library, but the S1.0 binders showed statistically significantly stronger calcium-dependent ELISA signals. Selections against thermostable green fluorescent protein, enzymatically biotinylated for magnetic bead capture, were even more striking: after one round of ribosome display and two rounds of phage display with off-rate selection, an enrichment factor of 427 was recorded, and ten unique sybody sequences emerged from twelve colonies analyzed. Fluorescence-detection size-exclusion chromatography showed that all ten shifted the elution profile of the fluorescent target, and biolayer interferometry confirmed nanomolar binding, with the best binder, named SH2, achieving a dissociation constant of 1.9 nanomolar.

The decisive experiment came next. When sybodies SH1 and SH2 were mixed with TGP and Legobody components, both assembled into stable complexes that could be pulled down through the maltose-binding protein’s affinity for amylose resin, detected directly by gel electrophoresis with no re-engineering of any kind. That intrinsic compatibility transforms the workflow for structural studies: a selection campaign that once ended with weeks of subcloning can now feed binders straight into Legobody assembly and cryo-EM grid preparation.

The authors are candid about remaining limitations. Validation covered only two soluble targets, and performance against the small membrane proteins that motivate the entire endeavor remains to be demonstrated. Sequencing also revealed instructive surprises, such as the strong underrepresentation of isoleucine at position 29 among functional binders despite its 20 percent abundance in the design, evidence that effective functional diversity, not raw theoretical diversity, ultimately governs library success. The team argues that accumulating sequencing data from naive and enriched libraries, mined with machine-learning approaches and shared through public repositories, should guide the next generation of synthetic nanobody libraries, turning empirical selection outcomes into ever-smarter designs.

Subject of Research: Design and validation of a ribosome display library for synthetic nanobody selection

Article Title: Design and validation of a ribosome display library for synthetic nanobody selection

Article References: Gu, W., Li, Y., Hong, J., Yue, Z., Zhang, Y., Fan, S., Shen, Z., Li, T., & Li, D. (2026). Design and validation of a ribosome display library for synthetic nanobody selection. Advanced Biotechnology, 4(2), Article 19. https://doi.org/10.1007/s44307-026-00112-z

Image Credits: AI Generated

DOI: 10.1007/s44307-026-00112-z

Keywords: nanobodies, sybodies, ribosome display, synthetic antibody library, Legobody, cryo-EM, structural biology, membrane proteins, CDR randomization, biolayer interferometry, phage display, protein engineering

The core challenge that MemBrain v2 addresses begins with segmentation. A cryo-electron tomogram is essentially a three-dimensional reconstruction assembled from a tilt series of two-dimensional projection images of a vitrified sample. Within that volumetric data, membranes appear as weak, noisy, curving sheets only a few nanometers thick, often distorted by the so-called missing wedge artifact that arises from physical limits on how far the sample can be tilted in the microscope. Early approaches to membrane segmentation relied on hand-crafted filters, edge detectors, and painstaking manual contouring, a process that could consume days of an expert’s time for a single tomogram and that varied substantially from one analyst to another. Such variability made large-scale, quantitative comparisons across cells, conditions, or organisms extremely difficult, effectively capping the throughput of the field.

MemBrain v2 builds on the deep-learning foundations laid by its predecessor, which introduced convolutional neural network models trained to recognize membrane density patterns that human eyes and classical algorithms routinely miss. The new version extends this philosophy across the entire analysis pipeline. Rather than providing a single segmentation model that researchers must then stitch into their own homemade workflows, the software packages the full sequence of steps: preprocessing of raw tomograms, automated segmentation of membranes, extraction of continuous membrane meshes from the segmented volumes, localization of membrane proteins relative to those meshes, and quantitative spatial statistics describing how proteins and curvature features are organized across the membrane surface. The result is a pipeline in which a user can move from a reconstructed tomogram to publication-ready membrane measurements with minimal manual intervention.

Technically, the segmentation engine in MemBrain v2 employs neural networks trained on curated, manually annotated datasets of tomograms spanning diverse biological contexts, from isolated organelles to intact cells prepared by focused ion beam milling. The models operate on three-dimensional patches of the tomogram, predicting per-voxel probabilities that a given location belongs to a membrane. Crucially, the developers have placed strong emphasis on generalization: the goal is that a network trained on one set of samples and imaging conditions will still perform reliably on tomograms acquired on a different microscope, with a different detector, or from a different biological system. This kind of cross-dataset robustness has been a persistent pain point in cryo-ET machine learning, where models frequently overfit to the specific noise characteristics and contrast regimes of their training data. Performance across heterogeneous datasets was therefore treated as a first-class evaluation criterion rather than an afterthought.

Once membranes are segmented, the software converts the voxel-level predictions into geometrically clean surface meshes, a step that is far less trivial than it sounds. Segmentation outputs are typically noisy at the pixel scale, containing holes, spurious protrusions, and disconnected fragments that would corrupt any downstream measurement of surface area, curvature, or protein spacing. MemBrain v2 incorporates methods to extract smooth, watertight representations of membrane surfaces, preserving fine topological features such as tight junctions, cristae junctions, organelle contact sites, and highly curved tubular structures. This geometric fidelity matters because many of the most interesting biological questions in modern cell biology hinge precisely on such features: how the folded inner membrane of a mitochondrion organizes its respiratory machinery, how the endoplasmic reticulum generates curved hubs that recruit certain proteins, or how viral replication compartments remodel host membranes into convoluted replication factories.

Perhaps the most consequential addition in version 2 is the integration of membrane protein localization into the same workflow. Subtomogram averaging has long allowed structural biologists to determine high-resolution structures of abundant, repetitive complexes, but mapping the broader landscape of membrane-associated proteins in situ, including those that are sparse, irregularly arranged, or conformationally heterogeneous, remains a formidable task. MemBrain v2 provides tools to detect and classify particles in the vicinity of segmented membranes, project their positions onto the extracted meshes, and compute spatial statistics that characterize their distribution: clustering tendencies, exclusion patterns, correlations with local membrane curvature, and nearest-neighbor relationships. By unifying segmentation and particle analysis in one software environment, the tool removes the error-prone handoffs between disconnected programs that have historically plagued multi-step cryo-ET analyses.

The significance of this integration extends well beyond convenience. Spatial organization of proteins on membranes is now understood to be a central regulatory principle in cell biology. The clustering of receptors can amplify signaling; the sorting of complexes into curvature-sensing domains can drive vesicle budding; the exclusion of certain proteins from contact sites can maintain organelle identity. Quantifying these patterns rigorously requires exactly the kind of joint membrane-and-protein analysis that MemBrain v2 enables. Instead of qualitative statements that a protein appears enriched on curved regions, researchers can now report statistically grounded measurements of enrichment, complete with the geometric context of the underlying membrane. This shift from descriptive to quantitative in situ analysis aligns cryo-electron tomography with the standards of rigor that fields such as light-sheet microscopy and single-cell genomics achieved years ago.

Accessibility has been a guiding concern throughout the design. Cryo-ET is a technique that sits at the intersection of biology, physics, and computer science, and many research groups possess deep biological questions but limited computational infrastructure. Earlier generations of analysis tools often assumed considerable programming expertise, requiring users to assemble pipelines from research code written by other laboratories, with little documentation and no guarantee of stability between versions. MemBrain v2 counters this with user-friendly interfaces, containerized installation options, thorough documentation, and standardized output formats designed to interoperate with the broader ecosystem of tomography software, including visualization platforms and subtomogram averaging packages. The developers have also made the trained models and processing tools openly available, consistent with a broader movement in structural biology toward open, reproducible computational methods that any laboratory can adopt, inspect, and extend.

The timing of such a tool is not accidental. Cryo-electron tomography is undergoing explosive growth, propelled by advances in direct electron detectors, automated data collection, focused ion beam milling of lamellae, and reconstruction algorithms that dramatically improve resolution and contrast. Large-scale initiatives now aim to image thousands of cellular volumes, generating data at a rate that makes manual analysis categorically impossible. In this environment, automated, reliable, generalizable analysis pipelines are not merely convenient; they are the precondition for the field’s ambition to build a quantitative atlas of cellular architecture. Tools like MemBrain v2 represent the computational counterpart to the hardware revolution, ensuring that the flood of tomographic data can be converted into biological insight rather than accumulating as unprocessed archives.

For the practicing researcher, the practical implications are immediate. A laboratory studying mitochondrial remodeling during stress, for example, could apply the pipeline across dozens of tomograms of control and treated cells, obtain consistent membrane segmentations, quantify changes in cristae morphology, map the redistribution of respiratory chain complexes, and test whether protein reorganization tracks with local membrane curvature, all within a unified framework. A virology group could chart how viral proteins reshape intracellular membranes as replication compartments mature. A neurobiologist could examine the nanoscale organization of synaptic vesicle clusters and presynaptic membrane specializations. In each case, the same underlying machinery of segmentation, mesh extraction, particle localization, and spatial statistics does the heavy lifting, freeing scientists to focus on experimental design and biological interpretation rather than on debugging bespoke image-analysis scripts.

As with any computational method, caveats remain. Deep-learning segmentations are probabilistic and can fail in unexpected regimes, particularly with extreme imaging conditions, unusual staining or labeling approaches, or membrane-like features such as dense protein coats that mimic lipid bilayers. Responsible use therefore still entails expert validation, and the developers emphasize that the tool is intended to accelerate and standardize expert workflows rather than eliminate judgment from the loop. Nevertheless, by demonstrating robust performance across diverse datasets and by wrapping the entire analysis chain into a coherent, accessible package, MemBrain v2 marks a meaningful step toward making the quantitative analysis of cellular membranes as routine as the imaging itself. If the trajectory of cryo-electron tomography continues on its current course, tools of this kind will become the standard infrastructure on which the next decade of in situ structural biology is built, transforming noisy three-dimensional images into a rigorous, comparative anatomy of the cell’s molecular geography.

Subject of Research: A deep-learning software pipeline for membrane segmentation and membrane protein spatial analysis in cryo-electron tomography

Article Title: MemBrain v2: an end-to-end tool for the analysis of membranes in cryo-electron tomography

Article References: Lamm, L., Zufferey, S., Zhang, H., Righetto, R. D., Waltz, F., Wietrzynski, W., Yamauchi, K. A., Burt, A., Liu, Y., Martinez-Sanchez, A., Ziegler, S., Isensee, F., Schnabel, J. A., Engel, B. D., & Peng, T. (2026). MemBrain v2: an end-to-end tool for the analysis of membranes in cryo-electron tomography. Nature Methods. https://doi.org/10.1038/s41592-026-03178-8

Image Credits: AI Generated

DOI: 10.1038/s41592-026-03178-8

Keywords: cryo-electron tomography, MemBrain v2, membrane segmentation, deep learning, membrane proteins, spatial analysis, structural biology, cell biology, organelle architecture, image analysis, subtomogram averaging, Nature Methods